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Comparison of Cognitive Changes in Patients
With Alzheimer's and Parkinson's Disease
Yaakov Stern, PhD; Marcus Richards, PhD; Mary Sano, PhD; Richard Mayeux, MD
\s=b\Objective.\p=m-\Tocompare cognitive changes in the demen-
tias of Parkinson's disease (PD) and Alzheimer's disease (AD).
Design.\p=m-\Caseseries, group comparisons.
Setting.\p=m-\Ambulatorycare referral center.
Patients.\p=m-\Consecutivesample of 14 patients with PD de-
mentia and 27 with probable AD matched for overall intel-
lectual function using a mental status test, as well as 1 non-
demented PD and 12 mild probable AD patients, similarly
matched for overall intellectual function. All demented pa-
tients met Diagnostic and Statistical Manual, Revised Third
Edition, criteria for dementia.
Main Outcome Measures.\p=m-\Performanceon a battery of
neuropsychological tests assessing verbal and nonverbal
memory, verbal fluency, and constructional ability.
Results.\p=m-\Nondementedand demented patients with PD
performed worse than their probable AD comparison groups
on verbal fluency and visuospatial tasks. Cognitive changes
attributable to dementia were similar in PD and probable AD
but were not identical. The patients with probable AD dem-
onstrated more marked change in memory performance with
delay.
Conclusions.\p=m-\Ourfindings suggest that when dementia
occurs in PD it is overlaid on cognitive changes that already
exist in nondemented patients but that the dementing process
in PD involves systems other than those responsible for cog-
nitive change in nondemented PD patients. We hypothesize
that in most cases, dementia in PD involves changes in a non-
dopaminergic neurotransmitter system but is not due to con-
comitant AD.
(Arch Neurol. 1993;50:1040-1045)
The extent to which the dementias of Parkinson's disease(PD) and Alzheimer's disease (AD) overlap remains
controversial. As Brown and Marsden1 point out, some in¬
vestigators have concluded that the two dementias differ in
etiology and phenomenology,2 while after reviewing the
same literature, others remain unconvinced.l:u We con¬
trasted performance of demented patients with AD and PD
on a battery of neuropsychological tests. The assumption
underlying this approach is that differences in the pattern
of neuropsychological changes may suggest ways in which
the pathology underlying the dementias differs. Several ex¬
tensive reviews of comparative studies exist.1"5Several methodological issues are important for compara¬
tive studies of neuropsychological performance in AD and
PD dementia. Both groups should meet the same criteria for
dementia. The diagnosis of dementia should not be exclu¬
sively based on neuropsychological testing because any po¬
tential test performance differences between the two groups
would lead to differential patterns of diagnosis. The two
groups should be matched for dementia severity, although
the most appropriate matching strategy is not immediately
apparent.1 Typically, matching has been based on brief men¬
tal status examinations that presumably assess general in¬
tellectual function or overall dementia severity. Few com¬
parative studies of probable AD (pAD) and PD dementia
have met these methodological criteria.6"13
For this study, we administered a range of neuropsycho¬
logical tests assessing verbal and nonverbal memory, verbal
fluency, and constructional ability to patients with pAD and
PD dementia. To diagnose dementia in both PD and pAD,
we used Diagnostic and Statistical Manual, Revised Third Edi¬
tion (DSM-III-R), criteria for primary degenerative demen¬
tia,14 which emphasize functional as well as cognitive im¬
pairment, and the NINCDS-ADRDA guidelines for the di¬
agnosis of  AD,15 which stress the process of ruling out other
potential causes of dementia. The diagnosis of dementia was
determined separately from the neuropsychological battery
we used.
We explored two different strategies for matching demen¬
tia severity. First, the pAD and PD dementia groups were
matched for overall intellectual function using a mental sta¬
tus examination. Because items on a mental status test tap
aspects of cognition differentially affected by one disease
over another, using total scores might result in unequal
matching. We therefore explored an alternate matching
strategy: matching the groups' performance on a specific
neuropsychological test, in this case a test of memory.
An additional methodological concern has not been ad¬
dressed by previous investigators. It is well recognized that
neuropsychological changes occur in nondemented PD pa¬
tients, including word-finding difficulties, visuospatial dys¬
function, and problems with some memory and executivedysfunction.416"18 Even after adequate matching for demen¬
tia severity in pAD and PD, differences in neuropsychologi-
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cal test performance might actually be a function ofcognitive
changes that already exist in nondemented PD patients and
that are separate from the dementing process. To clarify this
issue, we administered the same test battery to nonde¬
mented, moderately cognitively impaired PD and mild pAD
patients, similarly matched for overall intellectual function
or memory scores.
We hypothesized that neuropsychological test perfor¬
mance in PD dementia represents a combination of cognitive
changes that predate the onset of dementia and are present
in most nondemented patients, along with qualitatively dif¬
ferent cognitive changes that are unique to the presence of
dementia. While we predicted that the latter changes would
be similar to those seen in AD, we were interested in iden¬
tifying any areas of divergence since these might be infor¬
mative for understanding the basis of dementia in PD.
PATIENTS AND METHODS
Patients with PD (n=54) and pAD (n=58) provided informed con¬
sent, underwent neuropsychological testing, and were used as a
pool from which to select groups for comparisons of neuropsycho¬
logical test performance in pAD and PD. Not all patients were used
for comparisons because some could not be matched (as will be de¬
scribed) and some had incomplete data.
Diagnosis of idiopathic PD was made by a neurologist based on
the presence of two of the cardinal signs of resting tremor, brady-
kinesia, postural disorder, and rigidity, along with careful elimina¬
tion of other potential parkinsonian syndromes. For demented PD
patients, the diagnostic signs of PD were required to have been
present for at least 1 year prior to the onset of intellectual decline.
Prior to the analyses described herein, the records of the patients
with PD were reviewed by three investigators (Y.S., M.S., and R.M.)
who had followed them clinically and in previous studies. For each
patient, the clinicians reached a consensus dementia diagnosis us¬
ing DSM-III-R criteria for dementia14 and NINCDS-ADRDA criteria
for pAD,15 with the obvious exception of their having had a con¬
comitant illness, PD. Key considerations were whether patients had
sufficient memory and cognitive impairment for this diagnosis and
whether their cognitive impairment resulted in social or occupa¬
tional dysfunction. Twenty of the PD patients met these criteria for
dementia. The patients with pAD met DSM-III-R criteria for demen¬
tia as well as NINCDS-ADRDA criteria for pAD. All subjects were
free of other neurological illness or medical conditions that could
potentially be responsible for cognitive change or dementia.
Procedures
The following neuropsychological test battery was administered
to all subjects.
Modified Mini-Mental State Examination (mMMSE).—The
mMMSE19 was given as a test of general intellectual function.
This modification of the Mini-Mental State Examination20 has a
maximum score of 57, and reliability and validity have been
established.21
Selective Reminding Test (SRT).—In this list-learning task,22 the
subject attempts to recall a list of 12 verbally presented words. After
each recall attempt, the subject is reminded only of the words that
were not recalled and is asked to again attempt to recall the entire
list. This procedure is repeated for a total of 12 recall trials. The SRT
performance measures included (1) total recall: the total of all words
recalled on all trials, with a maximum score of 144 (12 words X 12
trials); (2) long-term retrieval: the total of words considered to have
been retrieved from long-term storage—words recalled on two suc¬
cessive trials (without an intervening reminder) were counted on
those two and all following trials in which they were recalled; and(3) intrusions: total instances of recalling words that were not on the
test list—these words were corrected the first time they were re¬
ported by the patient and were scored as intrusion errors each sub¬
sequent time they were reported (for intrusions, a higher score in¬
dicates poorer performance).
Wechsler Memory Scale.—Three subtests of this scale23 were ad¬
ministered: (1) logical memory: the subject attempts to recall ver¬
batim the content of two paragraphs of thematic material; (2) visual
reproduction: the subject attempts to draw three pictures from
memory after viewing each for 10 seconds; and (3) associate learn¬
ing: three trials are given to learn 10 word-pairs. For the logical
memory and visual reproduction subtests, a 15-minute delayed re-
test was given with no warning. Change scores, consisting of the
difference between the immediate and delayed recall scores, were
calculated for each subtest as indexes of change in recall perfor¬
mance with delay.
Controlled Oral Word Association Test (CFL).—For this test,24 the
subject is required to name as many words as possible beginning with
the letters Ici, IfI, and ///, with 1 minute allowed for each letter.
Category Naming.—Patients were required to generate words
for three categories: animals, food, and clothing. One minute was
allowed for each category.
Rosen Drawing Test.—This test25 consists of 15 designs that the
subject is asked to copy. Designs range in difficulty from simple
figures, such as circles and squares, to overlapping and three-
dimensional figures. Qualitative aspects of the constructions are
scored; parkinsonian features such as tremor do not influence
scoring.
Statistical Analysis
Analytic Strategy.—Two sets of comparisons of neuropsycho¬
logical test performance were made. In the first set, matching was
based on mMMSE scores and in the second set, groups were
matched on performance on SRT total recall. In both sets, demented
PD and pAD patients were contrasted, and then patients with pAD
were contrasted with nondemented, mildly impaired PD patients.
This latter match was possible for two reasons: some of the non¬
demented PD patients had cognitive impairment that did not affect
their social and occupational function; others had cognitive impair¬
ment that affected mMMSE scores but did not meet the described
criteria for dementia.
Because of the large number of variables involved, multivariate
analysis of covariance (MANCOVA) was used for between-group
contrasts of performance on the neuropsychological battery. Since
MANCOVAs require complete data for all measures analyzed, pa¬
tients with missing data on any test were eliminated. A total of eight
PD (two nondemented; six demented) and 19 pAD patients were
eliminated for this reason.
The matching procedure for the mMMSE scores was as follows.
Since we did not want the same patients with pAD used in both
comparisons and since the potential pool of pAD patients who
could be matched by mMMSE score to nondemented PD patients
was smaller, selection for this comparison took priority. A range of
mMMSE scores that contained the maximal number of nonde¬
mented PD patients and pAD patients was identified. There were
14 nondemented PD patients and 12 pAD patients in the mMMSE
score range of 43 to 52; there were 18 nondemented PD patients who
scored too high on the mMMSE to be included in this comparison.
Following this procedure, the remaining patients with pAD were
contrasted with the demented PD patients to ensure similarity of
mMMSE scores and demographic variables, and matching was de¬
termined to be adequate.
The second set of comparisons was similar, but matching was
based on performance on memory measure (total recall on the SRT).
The procedure used to derive the groups was equivalent to that de¬
scribed for matching by mMMSE score range.
Statistical Techniques.—Comparability of the groups on each
matching variable was assessed using Student's f tests. For the
MANCOVAs, the individual neuropsychological test scores were
used as dependent variables, and patient group was a between-
group factor (two levels). Hotelling's T2 statistic was selected to test
the multivariate group effect. To increase the accuracy of group
matching, variables on which the patient groups were matched were
also used as covariates. Kolmogorov-Smirnov goodness-of-fit tests
were applied to each test score to check for departures from normal¬
ity. Where a significant departure was found for any variable, that
Downloaded From: http://jamanetwork.com/pdfaccess.ashx?url=/data/journals/neur/16335/ by a Columbia University User  on 01/12/2017
Table 1.—Comparison of Demented Parkinson'sDisease (PD) and Probable Alzheimer's Disease (pAD)Groups Matched for Modified Mini-Mental StateExamination (mMMSE) Scores
Variables*
PD (n=14) pAD (n=27)
I I I I




















71.1 8.7 67.3 8.7 NSt
15.1 4.4 14.0 4.2 NSt
10.1 10.3 3.7 1.5
...38.1 6.1 35.1 6.1 NSt
44.9 13.0 49.8 16.2 NS
15.3 9.5 21.0 14.9 NS






















1.4 1.3 2.4 1.4 .023
0.2 0.4 1.1 1.4 .03
*SRT indicates Selective Reminding Test; WMS, Wechsler Memory
Scale; CFL, Controlled Oral Word Association Test; and NS, not significant.
tPvalues are from ftests. Remaining Pvalues are from univariate F tests
following a multivariate analysis of variance comparing all remaining vari¬
ables simultaneously.




Mean SD Mean SD
Age, y 59.9 8.9 73.2 6.7 .0011
Educations 13.9 2.5 15.3 3.6 NSt
Duration, y 6.6 3.4 3.2 1.9
mMMSE 47.6 2.7 46.4 2.4 NSt
SRT
Total recall 75.0 15.5 59.6 15.8 NS
Long-term retrieval 46.2 21.1 25.7 17.2 NS
Intrusions 1.2 2.6 3.2 3.0 .012
WMS
Logical memory 5.9 2.5 3.8 1.2 .038
Visual reproduction 5.4 3.2 4.1 3.0 NS
Associate learning 11.6 3.2 7.3 3.0 .03
CFL 9.9 3.3 13.7 5.4 .002
Category Naming 15.9 4.3 14.3 3.5 NS
Rosen Drawing Test 10.4 2.0 12.2 1.5 .052
Immediate-delayed recall
WMS logical memory 1.9 1.2 3.2 1.5 .02
WMS visual reproduction 2.8 2.9 3.8 3.0 NS
*See Table 1 for expansion of abbreviations.
tP values are from f tests. Remaining  values are from univariate F
tests following a multivariate analysis of variance comparing all remain¬
ing variables simultaneously.
variable was omitted from the multivariate analysis of variance, and
a Mann-Whitney Li test was used to assess group differences.
RESULTS
Disease Characteristics of PD Patients
All but one patient with PD included in the analyses were
optimally treated with dopamine replacement therapy for at
least 1 month prior to testing; the remaining patient was re¬
ceiving no dopamine replacement therapy. Four (three non¬
demented and one demented) patients were receiving anti-
cholinergic medication. Modal score on the Hoen and Yahr
scale was 3. One (demented) patient had a score of 1, seven(six nondemented, one demented) had a score of 2, and one(demented) had a score of 4.
Match for General Intellectual Function
pAD and Demented PD Patients.—There were 14 de¬
mented PD patients who were matched with 27 patients with
 
AD for general intellectual function on the mMMSE. Means
and SDs for these demographic variables and each neuro¬
psychological test score for the two groups are presented in
Table 1. Preliminary t tests revealed no differences between
these two groups in age, education, or mMMSE level.
A Kolmogorov-Smirnov test revealed a skewed distribu¬
tion with the Wechsler visual memory score. A Mann-
Whitney test revealed a significant group difference on this
variable (P=.014). The remaining variables were subjected
to MANCOVA, with age, education, and mMMSE as co-
variates.
The multivariate test revealed an overall group difference
with these variables (T2=0.87, P=.011). Corresponding
univariate F tests, with (1,36) df, showed that the following
variables contributed to this effect: CFL (F=9.01, P=.005),
Category Naming (F=20.76, P<.001), and Rosen Drawing
Test (F=14.23, P=.001). In all cases, performance was signifi¬
cantly poorer in the PD group.
Change scores between immediate and delayed Wechsler
Memory Scale were also analyzed. The visual reproductions
change score was significantly skewed. A Mann-Whitney
test showed a greater decline in patients with pAD than pa¬
tients with PD for this test (P=.03), although a floor effect for
immediate visual reproductions in PD patients should be
kept in mind (Table 1). The t tests revealed greater change in
logical memory for pAD than PD patients (f=2.36, P=.023).
In summary, demented PD patients showed impaired ver¬
bal fluency and constructional ability relative to patients
with pAD matched for overall intellectual ability. Perfor¬
mance on short-term memory tests was comparable except
for visual reproduction, but patients with  AD showed more
marked change in recall performance with delay on the logi¬
cal memory test.
pAD and Nondemented PD Patients.—There were 14
nondemented PD patients who were matched with 12 pa¬
tients with pAD for general intellectual function on the
mMMSE. Means and SDs for these demographic variables
and each neuropsychological test score for these two groups
are shown in Table 2. Preliminary f tests revealed no differ¬
ences in education or mMMSE level for these two groups.
However, patients with pAD were significantly older(f=4.22, P<.001).
All variables were normally distributed and were sub¬jected to MANCOVA, with mMMSE, age, and education as
covariates. The multivariate group effect was significant(T2=3.14, P=.007). Corresponding univariate F tests, with(1,21) df, showed that the following variables contributed to
this effect: SRT intrusion errors (F=7.62, P=.012), logical
memory (F=4.92, P=.038), associate learning (F=5.41, P=.03),
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Table 3.—Comparison of Demented PD and Mild pADGroups Matched for SRT Scores*
Variables*
PD(n=14) pAD (n=24)
I I I I





13.0 44.0 13.6 NSt
9.5 15.4 9.6 NSt
3.5 5.0 6.5 NSt
Age, y 71.1 8.7
Education, y 15.1 4.4





mMMSE 38.1 6.1 37.2 7.6 NS
WMS
Logical memory 3.2 2.0 3.3
Visual reproduction 0.2 0.4 2.0
Associate learning 7.1 2.2 6.8
CFL 6.2 2.6 8.4
Category Naming 6.6 2.3 10.0
Rosen Drawing Test 6.5 3.3 9.5
Immediate-delayed recall
WMS logical memory 1.4 1.3 2.8

















*See Table 1 for expansion of abbreviations.
tP values are from (tests. Remaining  values are from univariate F
tests following a multivariate analysis of variance comparing all remain¬
ing variables simultaneously.
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Rosen Drawing Test 10.3
Immediate-delayed recall
WMS logical memory 1.8
WMS visual reproduction 2.7
5.8 60.3 4.7 NSt
3.4 14.3 3.7 NSt
3.8 3.0 1.3
...
9.5 66.6 9.3 NSt
14.0 34.8 14.1 NSt



































*See Table 1 for expansion of abbreviations.
tP values are from f tests. Remaining  values are from univariate F
tests following a multivariate analysis of variance comparing all remain¬
ing variables simultaneously.
CFL (F=13.08, P=.002), and Rosen Drawing Test (F=4.25,
P=.052). For the memory tests, performance was better in the
patients with PD than in patients with pAD. However, the
reverse was true for the CEL test and the Rosen Drawing Test.
The Wechsler memory change scores were normally dis¬
tributed. The t tests revealed a significantly greater decline
in logical memory scores (t=2.5, P=.02) in patients with pAD.
In summary, nondemented PD patients showed superior
short-term memory performance compared with pAD pa¬
tients on three of four tests (considering the fewer intrusion
errors on the SRT). Patients with pAD showed more change
in recall performance with delay on the logical memory test.
However, the relatively impaired Rosen Drawing Test and
CFL scores found in demented PD patients were also present
in the nondemented group.
Match for Verbal Memory
pAD and Demented PD Patients.—There were 14 de¬
mented PD patients who were matched with 24 patients with
 
AD on the total recall scale of the SRT (Table 3). Preliminary
t tests revealed no differences in age, education, or total SRT
recall between these two groups.
An abnormal distribution was found for the visual repro¬
duction score. A Mann-Whitney U test revealed a poorer
score for this test in PD patients (P=.008). The remaining vari¬
ables were subjected to a MANCOVA, using age, education,
and mMMSE as covariates. The multivariate test for the
group effect was significant (T2=0.82, P=.028). Correspond¬
ing univariate F tests, with (1,33) df, showed that the follow¬
ing variables contributed to this effect: CFL (F=4.25, P=.047),
Category Naming (F=8.35, P=.007), and Rosen Drawing Test(F=8.78, P=.006). For all three of these tests, performance was
poorer in PD than pAD patients.
The change score for visual reproductions was skewed. A
Mann-Whitney U test revealed a greater decline in this test
score in patients with pAD (P=.018). A t test revealed a
greater decline in logical memory in pAD than PD patients(f=3.26, P=.002).
In summary, demented PD patients performed more
poorly than the group with pAD on Wechsler Memory Scale
visual reproduction, two verbal fluency tasks (CFL and Cat¬
egory Naming), and Rosen Drawing Test. Other tests of
short-term memory yielded comparable performance. There
was more marked change in recall performance with delay
in the group with pAD on the logical memory test.
 
AD and Nondemented PD Patients.—There were 12
nondemented PD patients who were matched with 12 pa¬
tients with pAD for performance on the total recall score of
the SRT and for age (Table 4). Preliminary t tests revealed no
differences in age, education, or SRT total recall between
these two groups.
All variables were normally distributed and were sub¬jected to MANCOVA, with the SRT total recall, education,
and age as covariates. A highly significant group effect was
found (T2=13.84, P<.001). Corresponding univariate F tests,
with (1,19) df, showed that the following variables contrib¬
uted to this effect: mMMSE total score (F=17.05, P<.001), SRT
intrusions (F=5.89, P=.025), logical memory (F=5.08, P=.036),
associate learning (F=9.56, P=.006), and visual reproductions(F=4.90, P=.039). Performance was poorer in the group with
pAD, while CFL performance was poorer in the PD group(F=4.48, P=.048). Wechsler memory change scores were nor¬
mally distributed. No group differences were found.
In summary, scores for the mMMSE and all memory tests
were poorer in the group with  AD, but patients with PD still
had poorer CFL performance than those with pAD.
COMMENT
Matching severity of dementia in two different diseases is
complex. To begin with, sources of functional impairment
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are potentially different in the two patient groups. The pri¬
mary defining feature of AD and its resulting functional in¬
capacity is cognitive change. In PD, motor signs are a major
cause of functional disability, but the DSM-III-R diagnostic
criteria for dementia require functional impairment result¬
ing from cognitive deficit. This can result in diagnostic er¬
rors. We attempted to minimize this possibility by carefully
considering severity of motor disability, extensively ques¬
tioning patients and informants, and investigating func¬
tional skills that should remain relatively unaffected by mo¬
tor changes of PD.
An additional complication in matching pAD and PD de¬
mentia is the well-documented cognitive change that occurs
in nondemented PD patients. By definition, these patients do
not meet DSM-III-R criteria for dementia. Still, some nonde¬
mented PD patients' cognition was sufficiently impaired to




Matching Based on mMMSE
Our results clearly demonstrate that visuospatial and ver¬
bal fluency performances are affected in both demented and
moderately impaired nondemented PD patients. In contrast,
there seems to be a qualitative difference in the pattern of
memory performance as PD patients become demented.
The CFL and Rosen Drawing Test scores in the nonde¬
mented PD group were worse than those in the mild pAD
group. These findings parallel previously described cogni¬
tive changes in nondemented patients with PD. Poor perfor¬
mance on visuospatial tasks such as the Rosen Drawing Test
and on verbal fluency tasks have often been reported in
PD.2629 Our findings strengthen the results of the other stud¬
ies since they were based on comparisons with pAD patients
and not merely with normal controls. Demented PD patients
also had impaired verbal fluency and constructional ability
relative to their matched group with pAD. Similarly, even
though it is putatively a test of memory, relative perfor¬
mance on the visual reproduction subtest of the Wechsler
Memory Scale also probably can be accounted for by the
strong visuospatial component of this test. In this case, non¬
demented PD patients performed similarly to their pAD
comparison group, while demented PD patients performed
worse than their comparison group. Thus, the relative per¬
formance deficits on these tests might best be viewed as re¬
flecting preexisting cognitive changes of PD on which the
later dementia of PD is superimposed. This concept is rein¬
forced by a supplementary analysis where we used MAN¬
COVA to contrast neuropsychological test performance in
the more mildly affected pAD patients (ie, mMMSE range of
43 to 52) with that in nondemented PD patients whose
mMMSE scores were too high to be included in this analyses,
ie, nondemented PD patients with mMMSE scores above 52.
Even in this group of intact PD patients, CFL scores were sig¬
nificantly worse than those in the pAD group, while Rosen
Drawing Test scores were comparable.
In contrast, our results suggest a qualitative difference in
memory performance between nondemented and de¬
mented PD patients. When nondemented PD patients' per¬formance on memory tests was compared with their
mMMSE-matched pAD group, the group with pAD per¬
formed more poorly on aspects of the SRT, logical memory,
and paired associate learning. When demented PD and pAD
patients were compared, performance on all immediate
memory tests was similar (except for the visuospatially
loaded visual memory test, where PD patients performed
more poorly). These data suggest that rather than a simple
quantitative worsening of memory, a qualitative change in
memory dysfunction occurs as PD patients become de¬
mented.
Nondemented PD patients made fewer intrusion errors on
the SRT, but they performed as poorly as their matched pAD
group on the total recall and long-term retrieval measures of
the SRT. Other groups have also reported memory difficul¬
ties in nondemented PD patients when they compared them
with healthy controls.10-30"32 Problems with list-learning pro¬
cedures, such as the SRT, have been attributed to difficulties
organizing material,4-30 but this issue is not settled. Still, there
are qualitative differences between nondemented and de¬
mented PD patients' performance on the SRT that may re¬flect different causal mechanisms. Specifically, when com¬
pared with the nondemented PD patients, there were more
intrusion errors in the pAD group, while demented PD pa¬
tients were comparable with their pAD comparison group in
the number of intrusion errors made. Finally, both logical
memory and paired associate learning performance was
comparable with pAD patients in the demented PD patients
but not in the nondemented ones.
Matching on the Basis of Verbal Memory
Matching pAD and PD patients on SRT performance wasintended to more directly calibrate the two groups on a single
key feature of dementia, as opposed to the mMMSE, which
includes items that tap many cognitive functions. When de¬
mented PD and pAD patients were matched on SRT total re¬
call, other aspects of immediate memory were also compa¬
rable. However, demented PD patients still performed
worse on verbal fluency tasks, drawing, and a visual
memory task requiring drawing. General intellectual func¬
tion, assessed by the mMMSE, was comparable.
In contrast, when nondemented PD patients were
matched to those with pAD based on SRT performance, all
other memory tests still yielded poorer performance in the
group with pAD. Also, the patients with pAD made more
intrusion errors on the SRT itself than did the patients with
PD. Furthermore, mMMSE performance was poorer in the
patients with pAD. This reinforces the idea that in PD, poorSRT performance is not associated with general cognitive de¬
cline or even decline across several memory domains. De¬
spite better memory performance and higher mMMSE
scores, the patients with PD performed worse on CFL than
the patients with pAD.
These findings complement those obtained by matching
for mMMSE. In both sets of comparisons, patients with PDhave difficulty with construction and verbal fluency tasks
whether or not they are demented, suggesting that these
deficits are present in nondemented patients and are inde¬pendent of the dementing process. However, the qualitative
difference between demented and nondemented PD pa¬
tients in memory performance was again noted.
Change in Memory Performance With Delay
Changescores,consistingofthedifferencebetween imme¬diate and delayed recall, were evaluated for three memory
tests: logical memory, associate recall, and visual reproduc¬
tion. Change scores on the visual reproduction test are not
meaningful because of the extremely poor baseline perfor¬
mance in the patients with PD. In both comparisons of de¬
mented pAD and PD patients, those with pÀD had higher
change scores on the logical memory test, indicating more
marked change in recall performance with delay, even
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though the immediate memory measures were comparable.
This suggests that while many aspects of memory loss are
comparable in demented PD and pAD patients, change
scores demonstrate a feature of memory loss that is more se¬
vere in pAD. This tendency for patients with pAD to show
more marked change in memory performance with delay
than demented PD patients has been described previously.11
In the two comparisons using nondemented PD patients,
the general trend was also for a greater change in memoryperformance with delay in the patients with pAD, which is
consistent with comparisons in the demented group.
Effect of Age
There was a large disparity in the ages of the nondemented
PD patients and their pAD comparison group. We addressed
this disparity by including age as a covariate in our analyses.
Despite their younger age, the nondemented PD patientsperformed more poorly than their pAD comparison group
on several tasks, and similarly on the SRT. In addition, when
patients were matched on SRT performance, no age differ¬
ences were noted, and results complemented those seen
from the mMMSE match. We concluded that the age dispar¬
ity did not influence our observations.
Dementia in PD and pAD
Our findings suggest that when dementia occurs in PD, it
is overlaid on cognitive changes that already exist in non¬demented patients. A widespread assumption, which hasbeen supported by studies of parkinsonism induced by
MPTP (l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine),33 is
that these preexisting changes are due to loss of dopamin-
ergic innervation of the basal ganglia, although this issue is
far from settled.34-35 While the data examined herein are
cross-sectional and do not directly assess changes in cogni¬
tion as patients with PD become demented, we propose that
as dementia emerges, there is a qualitative shift in the pattern
of cognitive deficits in PD, with substantial broadening and
worsening ofmemory dysfunction. The qualitative shift maybe associated with new changes in a nondopaminergic sys¬
tem. One possibility is that the new cognitive features asso¬
ciated with dementia result from the development of an AD-
like illness. This would explain the overall similarity in the
pattern of neuropsychological performance in the two dis¬
eases after accounting for the preexisting PD-related cogni¬
tive changes. However, although similarities far outweighed
differences in our comparisons, our observation of more
marked change in memory performance with delay in pAD
emphasizes the repeated observation that the dementias in
these two diseases are not completely homologous.6,8"13 On
the whole, our results most strongly support the idea that the
qualitative shift in cognition as dementia emerges in PD rep¬
resents the onset of degeneration in a nondopaminergic neu-
rotransmitter system but do not support the concept that de¬
mentia in PD is due to concomitant AD pathology. One likely
candidate is exacerbation of changes in the cholinergic sys¬
tem since changes in this system can be present in PD de¬
mentia even when pathological changes of AD are not.36
This study was supported by federal grants AG02802, AG07232,
and AG08702, by The Robertson Memorial Gift for Alzheimer's Dis¬
ease, and by The Parkinson's Disease Foundation, New York, NY.
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